期刊文献+

帕金森病大鼠中枢神经一氧化氮合成酶活性研究 被引量:1

Study on the activity of nitric oxide synthetase in the central nervous system of the rat with Parkinson's disease
在线阅读 下载PDF
导出
摘要 目的通过对帕金森病(Parkinson’s disease,PD)大鼠中枢神经系统一氧化氮合成酶(NOS)3种同工酶的活性变化的研究,探讨帕金森病发病的可能因素和机制。方法用6-羟多巴胺(6-OHDA)毁损单侧黑质建立大鼠向健侧旋转运动的帕金森病动物模型;采用分光光度法检测神经元型一氧化氮合成酶(nNOS)、内皮型一氧化氮合成酶(eNOS)、诱导型一氧化氮合成酶(iNOS)活性变化。结果与正常对照组相比,帕金森病组大鼠eNOS活性无明显变化;nNOS活性升高(P<0.05);iNOS活性显著升高(P<0.01)。结论具有神经毒性作用的nNOS、iNOS的升高,具有神经保护作用的eNOS活性未相应增加,可能是帕金森病发生发展的重要因素之一。 Objective To explore possible mechanism and pathogenic factors involved through studying changes in the activi-ty of 3 isoenzymes of nitric oxide synthetase (NOS) in the central nervous system of the rat with Parkinson' s disease (PD). Methods The rat model of PD was developed with the injection of 6-hydroxy dopamine (6-OHDA)into the striatum. Changes in the activity of neuronal nitric oxide synthetase (nNOS), endothelia nitric oxide synthetase (eNOS) and induced nitric oxide synthetase (iNOS)were monitored by spoctrophotometry. Results When compared with the animals in the normal group, it was shown that no significant chan- ges in the activity of eNOS could be detected for the animals in the experimental group with Parkinson' s disease, and the activity of nNOS and iNOS increased obviously (P 〈 0.05, P 〈 0.01 ). Conclusion Increased levels of neurotoxic nNOS and iNOS and the decreased level of neuroprotective eNOS on the other hand seemed to be one of the important pathogenic factors for the occurrence and de- velopment of Parkinson' s disease.
出处 《海军医学杂志》 2011年第4期245-248,共4页 Journal of Navy Medicine
关键词 帕金森病 中枢神经 一氧化氮合成酶 Parkinson' s disease Central nervous system Nitric oxide synthetase
  • 相关文献

参考文献12

  • 1包新民,舒斯云.大鼠立体定位图谱[M].北京:人民卫生出版社,1999:60-68.
  • 2Ramkumar K, Rohit S, Sarika S, et al. Nitric oxide synthase regulation and diversity: implications in Parkinson' s disease[ J]. Ann Neuraul, 2006, 15(4) : 280 -294.
  • 3Zhang HX, Tao L, Jiao XY, et al. Nitratlve thioredoxin inactivation as a cause of enhanced myovardial ischemia repeduaion injury in the aging heart[J]. Free Radic Biol Med, 2007, 43(1) : 39 - 47.
  • 4Stephen R, Narong S, David G. The role of nitric oxide in the neural control of breathing[ J ]. Resp Physiol Neurobiol, 2008, 164(2) : 63 -72.
  • 5Jeremy DM, Michael DS. Inhaled nitric oxide and neuroproteotoin in preterm infants[J]. Clin Perinato], 2008, 35(4) : 793 -807.
  • 6胡章颜.一氧化氮与细胞凋亡的研究进展[J].江西医学院学报,2005,45(3):176-178. 被引量:15
  • 7Zhang L, Dawson VL, Dawson TM. Role of nitric oxide in Parkinson disease[J]. Pharmacol Ther, 2006, 109(2) : 33 -40.
  • 8Davies IR, Zhang X. Nitric oxide selectiw electrodes[J]. Mehods Enzymol, 2008, 436(5) : 63 -95.
  • 9Ana N, Alberto B. Mitochondrial nitric oxide synthase, mitoehondrial brain dysfimctionin and mitochondria-targeted antioxidants [J]. Adv Drug Deliv Bey, 2008, 60(6) : 1534 -1540.
  • 10Anil K, Anant S. Possible nitric oxide modulation in protective effect of ( curcuma longa, zingiberaceae) against sleep deprivationinduced behavioral alterations and oxidative damage in mice[ J]. Phytomedieine, 2008, 15(8) : 577 -586.

二级参考文献20

  • 1Palmer RM,Ferrige AG,Moncada.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor[J].Nature,1987,327(6 122):524-526.
  • 2Nicotera P,Brune,Bagetta G.Nitric oxide:inducer or suppressor of apoptosis?[J].Trends Pharmacol Sci,1997,18(6):189-190
  • 3Megson IL.Nitric oxide donor drugs[J].Drugs Fut,2000,25:701-715.
  • 4Butler AR,Rhodes P.Chemistry;analysis;and biological roles of S-nitrosothiols[J].Anal Biochem,1997,249(1):1-9.
  • 5Albin JE,Cui S.Nitric oxide-mediated apoptosis in murine peritoneal macrophages[J].Immunol,1993,150(11):5 080-5 085
  • 6Brune B,Zhou J,Von Knethen A.Nitric oxide,oxidative stress,and apoptosis[J].Kidney Int Suppl,2003,84:22-27.
  • 7Brown GC,Borutaite V.Nitric oxide ,mitochondria,and cell death[J].IUBMB Life,2001,52(3~5):189-195.
  • 8Clockzin S,Von Knethen A.Activation of the cell death program by nitric oxide involves inhibitiob of the proteasome[J].Boil Chem,1999,274:19 581-19 586.
  • 9Kolb JP.Mechanisms involved in the pro-,and anti-apoptotic role of NO in human leukemia[J].Leukemia,2000,14(9):1 685-1 694.
  • 10Piantodasi CA,Tatro LG,Whorton AR.Nitric oxide,differential effects of ATP on mitochondrial permeability transition[J].Nitric Oxide,2002,6:45-60.

共引文献15

同被引文献15

  • 1刘世伟,李红霞.国内针灸治疗帕金森病概况[J].中国现代药物应用,2007,1(9):71-72. 被引量:4
  • 2覃琥云.一氧化氮(NO)的生理作用及临床意义[J].四川生理科学杂志,2000,22(2):11-13. 被引量:11
  • 3刘存志,于建春,李谈,丁晓蓉,远慧茹,韩景献.针刺对多发梗塞性痴呆大鼠海马nNOS mRAN及蛋白表达的影响[J].针刺研究,2005,30(4):199-202. 被引量:7
  • 4THOMAS B, BEAL MF. Parkinson's disease[ J ]. Hum Mol Genet, 2007,16(2) :R183 - 194.
  • 5WALKINSHAW G,WATERS CM. Induction of apoptosis in cate- cholaminergic PC12 cells byL-DOPA. Implication for the treatment of Parkinson's disease [ J ]. J Clin Invest, 1995,95 ( 6 ) : 2458 - 2464.
  • 6KAVYA R,SALUJA R,SlNGH S,et al. Nitric oxide synthase regu- lation and diversity: Implications in Parkinsonp's disease[ J ]. Ni- tric Oxide ,2006,15 (4) :280 - 294.
  • 7DAVIES IR, ZHANG X. Nitric oxide selective electrodes [ J ]. Methods Enzymol.2008 ,436 :63 -95.
  • 8CENGEL A, SAHINARSLAN A. Nitric oxide and cardiovascular system[J]. Anadolu KardiyolDerg,2006,6:364 -368.
  • 9AQUILANO K, BALDELLI S, ROTILIO G ,et al. Role of Nitric Ox- ide Synthases in Parkinson's Disease: A Review on the Antioxidant and Anti-in? ammatory Activity of Polyphenols [ J ]. Neuroche Res,2008,33(12) :2416 -2426.
  • 10BEAL MF. Excitotoxieity and nitric oxide in Parkinson's disease pathogenesis[ J]. Ann Neurol, 1998,44-(3 suppl 1 ) :S110 - 114.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部